Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[11/09/2020 | 20:03]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4w3-2BuwHXZn8HWz-2ByXmXuPQ4DvJoITzJeueNXfZgTc=
kzseZ9Zp2YrJmZiI16gOGTA5-2B-2BGCVA0wifg0NxI6_H_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-2Bw2SkdbLpsvw1RnQ9QS2y-2BC=
LGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB26gB2-2FA-2FR-2B9F1G9zdiHGZ=
Nitu1VtTaSHBaiW4LWiJrUAlkbJovRReALt35EesN47AkLHpub29FOqbzQOAnNdpjHAWYqEe-2F=
4Go9cAmnCfftxpqRNlh-2F-2BMy7EBY-2FShd98wjJmWNy9tzKV5Boi4PrUbAhMYAoak8-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 11 September 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regu=
lated informationIn accordance with article 8:6 of the Royal Decree executi=
ng the Belgian Code of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=
=E2=80=9D or the =E2=80=9CCompany) (Euronext Brussels: UCB) announces that,=
following exercises of stock options by members of its personnel, it has d=
isposed of UCB shares OTC in view of deliveries of these shares to the rele=
vant members of the personnel, within the framework of the Long Term Incent=
ive Program of the UCB Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4w3-2BuwHXZn8HWz-2Bufq7qPed0sboBCZpVDV4dSxVvJ=
BmtU2eh-2BKsZ06-2Bx63W2j8FnQhBkEpWo4K81UG62ZGV_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-2Bw2SkdbLpsvw1RnQ9QS2y-2BC=
LGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB26gB2-2FAw7J9Ispf4JL7yHULif=
Ao9t1eY1XzQEIti1bIIteWiQOhxsMzJv0LlUi-2Bnt6C06UC0KkWqCg6MSyYeUy7KV5dBYunPqJ=
DkwIv4WBD9NznoHDIB4sNpKOMuLHPd6RTapccL9Slj4Wfu-2Fl-2BFP2xSiBc80-3D

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3Di2ZZ_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wZgKVBNj-2BoSrt92Luc=
27ku6O6HstN5lCnWjbPW-2Bw2SkdbLpsvw1RnQ9QS2y-2BCLGcPecc7x-2BDZBtpuK-2F7sUg7D=
ebo-2BUwUG-2BmBZsJrB26gB2-2FA0JcggsQ7F-2BU9finV-2F1yCW2hS-2FvxyQ56DxU3lmYiW=
fwtPU5hNRmyWvxguTdDDNGoZ4KrOkknF53USQZ1xISvzwaskUk9SbSYpbgSBO6Y0luYQyZZNim6=
EuvV-2FHG51ILL4MQAOOB-2Bnd97O3nFEyj33Bo-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news

GenericFile
200911 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4w3-2BuwHXZ=
n8HWz-2Buq7MEn-2BLbmp0miHr6ceHOTaidrR4-2Fpv34viwe4WhtEY-3DbZZc_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-2Bw2SkdbLp=
svw1RnQ9QS2y-2BCLGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB26gB2-2FAyL=
MdZafIg1g7yjTWdXpH6EQRHO9dau85uAe-2F9xUjzievL9S8K-2Ff4kFF-2BPJJtBh-2F5cZ5i9=
-2BNMCrfvxwA4v6ftW0sD-2FevTjenUkUtDWhyLgoaxEp1xvnTdCT-2F69LTmN1jm4cxpCSVUpW=
kZhE9Ok-2B0mKI-3D GenericFile
200911 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4w3=
-2BuwHXZn8HWz-2BDTRjrTddvGAZSsOP9-2BBDm9ZUwMSYL1nZF404S50FkNU-3De8yv_xDPID0=
vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB5=
2Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-2Bw2=
SkdbLpsvw1RnQ9QS2y-2BCLGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB26gB2=
-2FA7tO6Iqv7TA53ZTtLbnLjRioADoA95VmrX4nydBfMXwiYpr-2FFgponyYo39n1UIchq82nr1=
NiaF1IlBQvOGZeYqQfm1uw6HsGzHjwOBnMmkjSZyLiUWKky1GoXXfOb8tfA77MIsM22wqFjEkF8=
2k6OWI-3D GenericFile
200911 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4=
w3-2BuwHXZn8HWz-2B-2FargqSgw4PlLVmmYW2qDER-2B8miffDkuvFCZNc5LanB8-3Da5P-_xD=
PID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZ=
lGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-=
2Bw2SkdbLpsvw1RnQ9QS2y-2BCLGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB2=
6gB2-2FA8NE5DpNkAjlQZWKiFsg206Q7FYVeBTQzsigLQiMAP27y-2Fao3LKJhnHdx56t68FoY-=
2B6ccW1BVr9gY0DS1g-2FdubTpHJqjPnvIz7BFAwVSYbZmB2z9v7uDyMNMYIrgLhD-2Bjok-2Fm=
nItCC31eXRTPauoCsM-3D Image
Chart 1 Sept 11 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED=
-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ekbY-2Firg4w3-2BuwHXZn8HWz-2Bufq7=
qPed0sboBCZpVDV4dSdcx88plsofazN2VLRy5V0-3DLZ6V_xDPID0vOuylFAU8fv4e60wei4Jxq=
EGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2=
F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O6HstN5lCnWjbPW-2Bw2SkdbLpsvw1RnQ9QS2y-2BC=
LGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2BUwUG-2BmBZsJrB26gB2-2FAy-2F2aZKUmdnDwvvi-=
2BPOWnHAyxZgFmAGo45yHm-2F0Dz5M3-2FhlrbnOSByUJgGzqutXfgZigOVljl5-2B9gBBp-2Fu=
xZQOrFVOZLrdFmqqTaIRUM-2BRLFCXZQNKVGw-2FHxMZWNke8zqjmNOrraQFQD7lrYtvGMkvY-3=
D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXKt5o1pZCfjo5xqWkL5BC7nbSbW7uLa0=
yfpE3w0BvpxAvm0V9x-2BuWjqkMjXbBoHd9SNkOIrm2wvCbiBcwxxrqlUb0Ln-2FWUkyHpDSK9a=
fjE8A-3DD6x3_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvP=
s6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wZgKVBNj-2BoSrt92Luc27ku6O=
6HstN5lCnWjbPW-2Bw2SkdbLpsvw1RnQ9QS2y-2BCLGcPecc7x-2BDZBtpuK-2F7sUg7Debo-2B=
UwUG-2BmBZsJrB26gB2-2FA-2F3aMez928TDNtuaioSIqIAlbCOo4cc2gXa0JG5ZK3gJb5Sw6qr=
Ld0crpri69OOlXyZ7O48N4fRh-2BeGTftwwwcSzhahVUVILfx7cX8ZDBbOoZWZDlhLW2zs4aGeZ=
yN8pM7jtfIjwzq-2BeXntYx7jmRbI-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=